These conditions include but are not limited to obesity, diabetes, sleep apnea, and sexual health. One of the company’s noted products is Qsymia. This is a combination drug that contains Phentermine and Topiramate. Topiramate is often prescribed by doctors alongside Phentermine to help increase weight loss results and to help curb the intense cravings that can come along with the decreased caloric intake that patients must carry out when taking Phentermine and Topiramate prescriptions. Vivus noted the dramatic and noteworthy results that individuals were getting with the Phentermine and Topiramate combo and made the genius and innovative move to create one medication that contains both. This has made the weight loss process for obese individuals much easier. Phentermine and Topiramate are often prescribed to individuals whose health is at risk due to obesity. Comorbid disorders that can come along with obesity include heart disease, diabetes, high blood pressure and premature death. Many people have a negative outlook on “diet pills,” but Qsymia is far from your average over the counter diet pill. It is a prescription drug prescribed to those whose obesity has become a risk to their health. This combination drug has been a life saver for those who are struggling with taking and keeping the weight off.
Vivus engages in clinical trials for the medications they manufacture. Reviews of these trials can be found on the company website at www.vivus.com. They focus on bringing awareness and education to patients and the medical community through their research. They also publish their research results through the National Institutes of Health registry, which can be found at www.clinicaltrials.gov. Here you can review current human trials that are researching treatment for individuals suffering with serious and/or life threatening diseases and disorders. Qsymia is Vivus’s breakthrough product and the manufacture of this medication has shown to help many individuals suffering with obesity.
Vivus’s Board of Directors includes experienced individuals who have worked in the pharmaceutical industry for much of their careers. CEO, Seth H. Z. Fischer, has had involvement with Trius Therapies Inc. and BioSig Technologies, Inc. He served as a chairman for Johnson & Johnson for almost 30 years. He spent time as president of Ortho-McNeil Pharmaceuticals and has had much experience with Topamax (Topiramate) during his career.  ​He has also been involved with the production and manufacture of medications for analgesic, anti-infective, cardiovascular, neurologic, psychiatric, and women’s health issues. He passionately works alongside a Board of Directors with pursuits similar to his own. This board includes David York Norton, Jorge Plutzky M.D., Eric W. Roberts, Herman Rosenman, Allen L. Shaw, and Mayuran Sriskandarajah.
5 stars rating Vivus Qsymia
5 stars - "My experience with Qsymia is very positive. I was able to lose 30 pounds in about 3 months. Thank you!" Based on 110,000 Votes!
 This Board of Directors touts extensive college and post-collegiate education and experience, ensuring top standards of safety and quality for patients who are suffering with life-threatening diseases and disorders. Vivus also has a passionate whole staff dedicated to their mission of creating treatments to save lives as well as improve the quality of life for patients across the United States and Europe.